Investigation of anxiety and depression in patients from the emergency department during COVID-19 epidemic
OBJECTIVE: To investigate the status of anxiety and depression in patients requiring emergency treatment during the epidemic of COVID-19 to identify the patients with acute psychological stress disorder.
METHODS: During the COVID-19 epidemic, the medical staff divided the patients visiting the emergency department into suspected group, fever group and control group through interview of the patients at triage. Self-rating anxiety scale (SAS) and self-rating depression scale (SDS) were distributed to each patient, and a trained medical staff was responsible for assisting the patient to complete the scales.
RESULTS: A total of 557 sets of scales were distributed, including 211 in suspected COVID-19 case group, 167 in fever group and 179 in the control group. A total of 516 scales were retrieved, including 197 in suspected case group, 151 in fever group and 168 in control group. In the 3 groups, the incidence rates of anxiety and depression were 57.87% and 58.88%, 48.34% and 43.71%, and 18.31% and 18.99%, respectively, and the rates were significantly higher in suspected group and fever group than in the control group (P < 0.01), and significantly higher in suspected group than in fever group (P < 0.05). The standardized anxiety and depression scale scores in suspected case group, fever group and control group were 57.38±16.25 and 42.58±14.27, 51.23±15.29 and 38.32±15.39, and 32.58±17.8 and 12.25±12.94, respectively. Compared with the control group, both suspected case group and fever group had significantly higher standard scores for anxiety and depression (P < 0.01), and suspected case group had significantly higher standardized scores than fever group (P < 0.01).
CONCLUSIONS: Among the patients visiting the emergency treatment, the patients with suspected COVID-19 and common fever are more likely to develop anxiety and depressive symptoms.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:40 |
---|---|
Enthalten in: |
Nan fang yi ke da xue xue bao = Journal of Southern Medical University - 40(2020), 9 vom: 30. Sept., Seite 1369-1372 |
Sprache: |
Chinesisch |
---|
Beteiligte Personen: |
Wang, Qingxia [VerfasserIn] |
---|
Links: |
---|
Themen: |
Acute psychological stress disorder |
---|
Anmerkungen: |
Date Completed 01.10.2020 Date Revised 18.12.2020 published: Print Citation Status MEDLINE |
---|
doi: |
10.12122/j.issn.1673-4254.2020.09.23 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM315609079 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM315609079 | ||
003 | DE-627 | ||
005 | 20231225155301.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||chi c | ||
024 | 7 | |a 10.12122/j.issn.1673-4254.2020.09.23 |2 doi | |
028 | 5 | 2 | |a pubmed24n1051.xml |
035 | |a (DE-627)NLM315609079 | ||
035 | |a (NLM)32990239 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a chi | ||
100 | 1 | |a Wang, Qingxia |e verfasserin |4 aut | |
245 | 1 | 0 | |a Investigation of anxiety and depression in patients from the emergency department during COVID-19 epidemic |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 01.10.2020 | ||
500 | |a Date Revised 18.12.2020 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a OBJECTIVE: To investigate the status of anxiety and depression in patients requiring emergency treatment during the epidemic of COVID-19 to identify the patients with acute psychological stress disorder | ||
520 | |a METHODS: During the COVID-19 epidemic, the medical staff divided the patients visiting the emergency department into suspected group, fever group and control group through interview of the patients at triage. Self-rating anxiety scale (SAS) and self-rating depression scale (SDS) were distributed to each patient, and a trained medical staff was responsible for assisting the patient to complete the scales | ||
520 | |a RESULTS: A total of 557 sets of scales were distributed, including 211 in suspected COVID-19 case group, 167 in fever group and 179 in the control group. A total of 516 scales were retrieved, including 197 in suspected case group, 151 in fever group and 168 in control group. In the 3 groups, the incidence rates of anxiety and depression were 57.87% and 58.88%, 48.34% and 43.71%, and 18.31% and 18.99%, respectively, and the rates were significantly higher in suspected group and fever group than in the control group (P < 0.01), and significantly higher in suspected group than in fever group (P < 0.05). The standardized anxiety and depression scale scores in suspected case group, fever group and control group were 57.38±16.25 and 42.58±14.27, 51.23±15.29 and 38.32±15.39, and 32.58±17.8 and 12.25±12.94, respectively. Compared with the control group, both suspected case group and fever group had significantly higher standard scores for anxiety and depression (P < 0.01), and suspected case group had significantly higher standardized scores than fever group (P < 0.01) | ||
520 | |a CONCLUSIONS: Among the patients visiting the emergency treatment, the patients with suspected COVID-19 and common fever are more likely to develop anxiety and depressive symptoms | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a acute psychological stress disorder | |
650 | 4 | |a self-rating anxiety scale | |
650 | 4 | |a self-rating depression scale | |
700 | 1 | |a Cao, Xiaoxia |e verfasserin |4 aut | |
700 | 1 | |a Wu, Xiuying |e verfasserin |4 aut | |
700 | 1 | |a Liu, Jiangfeng |e verfasserin |4 aut | |
700 | 1 | |a Xie, Jingwen |e verfasserin |4 aut | |
700 | 1 | |a Hou, Deren |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Nan fang yi ke da xue xue bao = Journal of Southern Medical University |d 2006 |g 40(2020), 9 vom: 30. Sept., Seite 1369-1372 |w (DE-627)NLM16087646X |x 1673-4254 |7 nnns |
773 | 1 | 8 | |g volume:40 |g year:2020 |g number:9 |g day:30 |g month:09 |g pages:1369-1372 |
856 | 4 | 0 | |u http://dx.doi.org/10.12122/j.issn.1673-4254.2020.09.23 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 40 |j 2020 |e 9 |b 30 |c 09 |h 1369-1372 |